trending Market Intelligence /marketintelligence/en/news-insights/trending/NDAqdBe7OD2zv8fYXw1JzA2 content esgSubNav
In This List

Eagle Pharmaceuticals names president

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Eagle Pharmaceuticals names president

Eagle Pharmaceuticals Inc. appointed David Pernock president and chief commercial officer, effective January 2017.

Pernock, who will report to CEO Scott Tarriff, will oversee all commercial strategy and execution for Eagle's product portfolio.

Pernock most recently was the CEO of gene therapy biotechnology company Fibrocell Science and previously was GlaxoSmithKline plc's senior vice president of pharmaceuticals, vaccines, oncology, acute care and HIV divisions.

Pernock has been serving Eagle Pharmaceuticals as a director since April 2015. He will give up this position when his new role takes effect.